BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 23499530)

  • 1. Involvement of heparanase in atherosclerosis and other vessel wall pathologies.
    Vlodavsky I; Blich M; Li JP; Sanderson RD; Ilan N
    Matrix Biol; 2013 Jun; 32(5):241-51. PubMed ID: 23499530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage activation by heparanase is mediated by TLR-2 and TLR-4 and associates with plaque progression.
    Blich M; Golan A; Arvatz G; Sebbag A; Shafat I; Sabo E; Cohen-Kaplan V; Petcherski S; Avniel-Polak S; Eitan A; Hammerman H; Aronson D; Axelman E; Ilan N; Nussbaum G; Vlodavsky I
    Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):e56-65. PubMed ID: 23162016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Versatile role of heparanase in inflammation.
    Goldberg R; Meirovitz A; Hirshoren N; Bulvik R; Binder A; Rubinstein AM; Elkin M
    Matrix Biol; 2013 Jun; 32(5):234-240. PubMed ID: 23499528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparanase involvement in physiology and disease.
    Nasser NJ
    Cell Mol Life Sci; 2008 Jun; 65(11):1706-15. PubMed ID: 18425416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparanase: A Novel Therapeutic Target for the Treatment of Atherosclerosis.
    Nguyen TK; Paone S; Chan E; Poon IKH; Baxter AA; Thomas SR; Hulett MD
    Cells; 2022 Oct; 11(20):. PubMed ID: 36291066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparanase: a rainbow pharmacological target associated to multiple pathologies including rare diseases.
    Rivara S; Milazzo FM; Giannini G
    Future Med Chem; 2016 Apr; 8(6):647-80. PubMed ID: 27057774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteoglycans in health and disease: new concepts for heparanase function in tumor progression and metastasis.
    Barash U; Cohen-Kaplan V; Dowek I; Sanderson RD; Ilan N; Vlodavsky I
    FEBS J; 2010 Oct; 277(19):3890-903. PubMed ID: 20840586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparanase alters arterial structure, mechanics, and repair following endovascular stenting in mice.
    Baker AB; Groothuis A; Jonas M; Ettenson DS; Shazly T; Zcharia E; Vlodavsky I; Seifert P; Edelman ER
    Circ Res; 2009 Feb; 104(3):380-7. PubMed ID: 19096032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparanase: multiple functions in inflammation, diabetes and atherosclerosis.
    Vlodavsky I; Iozzo RV; Sanderson RD
    Matrix Biol; 2013 Jun; 32(5):220-2. PubMed ID: 23499526
    [No Abstract]   [Full Text] [Related]  

  • 10. Biology of the Heparanase-Heparan Sulfate Axis and Its Role in Disease Pathogenesis.
    Vlodavsky I; Barash U; Nguyen HM; Yang SM; Ilan N
    Semin Thromb Hemost; 2021 Apr; 47(3):240-253. PubMed ID: 33794549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparanase multiple effects in cancer.
    Nadir Y; Brenner B
    Thromb Res; 2014 May; 133 Suppl 2():S90-4. PubMed ID: 24862152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparanase: Historical Aspects and Future Perspectives.
    Khanna M; Parish CR
    Adv Exp Med Biol; 2020; 1221():71-96. PubMed ID: 32274707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell surface localization of heparanase on macrophages regulates degradation of extracellular matrix heparan sulfate.
    Sasaki N; Higashi N; Taka T; Nakajima M; Irimura T
    J Immunol; 2004 Mar; 172(6):3830-5. PubMed ID: 15004189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transgenic or tumor-induced expression of heparanase upregulates sulfation of heparan sulfate.
    Escobar Galvis ML; Jia J; Zhang X; Jastrebova N; Spillmann D; Gottfridsson E; van Kuppevelt TH; Zcharia E; Vlodavsky I; Lindahl U; Li JP
    Nat Chem Biol; 2007 Dec; 3(12):773-8. PubMed ID: 17952066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparanase induces tissue factor pathway inhibitor expression and extracellular accumulation in endothelial and tumor cells.
    Nadir Y; Brenner B; Gingis-Velitski S; Levy-Adam F; Ilan N; Zcharia E; Nadir E; Vlodavsky I
    Thromb Haemost; 2008 Jan; 99(1):133-41. PubMed ID: 18217145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-faceted substrate specificity of heparanase.
    Peterson SB; Liu J
    Matrix Biol; 2013 Jun; 32(5):223-7. PubMed ID: 23499529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of heparanase inhibitors in cancer therapy.
    Heyman B; Yang Y
    Exp Hematol; 2016 Nov; 44(11):1002-1012. PubMed ID: 27576132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A functional heparan sulfate mimetic implicates both heparanase and heparan sulfate in tumor angiogenesis and invasion in a mouse model of multistage cancer.
    Joyce JA; Freeman C; Meyer-Morse N; Parish CR; Hanahan D
    Oncogene; 2005 Jun; 24(25):4037-51. PubMed ID: 15806157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparanase in inflammation and inflammation-associated cancer.
    Meirovitz A; Goldberg R; Binder A; Rubinstein AM; Hermano E; Elkin M
    FEBS J; 2013 May; 280(10):2307-19. PubMed ID: 23398975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparanase: From basic research to therapeutic applications in cancer and inflammation.
    Vlodavsky I; Singh P; Boyango I; Gutter-Kapon L; Elkin M; Sanderson RD; Ilan N
    Drug Resist Updat; 2016 Nov; 29():54-75. PubMed ID: 27912844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.